Dr. Christopher Peters is a partner of Radiation Medicine Associates of Scranton (RAMAS) and serves as medical director of NROC.
He is the director of clinical research at NROC, and serves as the Principal Investigator for NROC's full member status in the Radiation Therapy Oncology Group (RTOG). In 2012, Dr. Peters joined the board of directors of the Northeast Regional Cancer Institute (NRCI). He is an Associate Professor of Medicine at The Geisinger Commonwealth School of Medicine (GCSOM) and Director of the 4th year GCSOM elective in radiation oncology.
Dr. Peters is a graduate of the University of Pennsylvania, Philadelphia, and received his Doctor of Medicine degree from Case Western Reserve University, Cleveland, where he was elected into the Alpha Omega Alpha national medical honor society. After completing an internship in Internal Medicine at Case Western Reserve Metrohealth, he performed his Radiation Oncology residency at Mount Sinai Hospital, New York City, serving as Chief Resident in his final year.
Dr. Peters is board certified in Radiation Oncology. He is also experienced in realtime planning for prostate Brachytherapy, and his clinical research on prostate cancer yielded him the 2006 Clinical/Basic Science Research Award from ASTRO, the American Society for Therapeutic Radiology and Oncology. This award is given annually for the best clinical resident abstract.
Dr. Peters is a member of several medical societies including the American Society of Clinical Oncology (ASCO), ASTRO, and serves on ASTRO's government relations committee. He is also a scientific reviewer for the International Journal of Radiation Oncology, Biology and Physics, and has published numerous scientific articles in translational and clinical prostate cancer research.